This trial is set within a broader context of evolving SBRT applications, reflecting a significant trend in oncological treatments toward higher dose intensities over fewer sessions.
← all excerpts
SMILE-stereotactic multiple fraction radiotherapy for non-spine bone metastases: study protocol for a multicenter, open-label phase III randomized controlled trial.
1
—
—